Athira Pharma, Inc.
ATHA
$0.36
$0.01885.51%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 65.28% | 45.01% | 12.83% | 9.25% | 5.33% |
Total Depreciation and Amortization | 0.41% | -0.82% | -0.41% | -0.82% | 2.54% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -33.91% | 13.19% | 36.54% | 12.04% | -1.00% |
Change in Net Operating Assets | -238.61% | -977.99% | -61.54% | -48.46% | -96.58% |
Cash from Operations | 43.17% | 1.06% | 4.01% | 8.04% | 1.49% |
Capital Expenditure | -- | -- | 100.00% | 15.15% | 97.93% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -156.35% | -144.00% | -12.94% | -18.23% | -63.52% |
Cash from Investing | -156.37% | -144.00% | -12.81% | -18.24% | -63.29% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -77.63% | -- | -38.84% | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -77.63% | -- | -38.84% | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -72.50% | -45.78% | -50.94% | -48.14% | -235.39% |